10626794 |
Deletion of the carboxyl-terminal exons of K-sam/FGFR2 by short homology-mediated recombination, generating preferential expression of specific messenger RNAs
Sakamoto, H,
Shibuya, T,
Kuwahara, Y,
Yanagihara, K,
Nezu, M,
Ishii, H,
Sasaki, H,
Terada, M,
Makuuchi, M,
Ueda, T,
Mafune, K
|
Cancer Res |
1999 |
18337450 |
Involvement of fibroblast growth factor receptor 2 isoform switching in mammary oncogenesis
Der, CJ,
Cha, JY,
Lambert, QT,
Reuther, GW
|
Mol Cancer Res |
2008 |
17505008 |
AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor
Fukuoka, K,
Yamada, Y,
Yanagihara, K,
Nishio, K,
Sasaki, H,
Kimura, H,
Takeda, M,
Tamura, T,
Komatsu, T,
Yokote, H,
Arao, T,
Saijo, N
|
Clin Cancer Res |
2007 |
2377625 |
K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes
Sakamoto, H,
Odagiri, H,
Miyagawa, K,
Sugimura, T,
Katoh, O,
Yoshida, T,
Naito, K,
Hattori, Y,
Terada, M,
Nakatani, H
|
Proc Natl Acad Sci U S A |
1990 |
15561780 |
Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells
Moffa, AB,
Ethier, SP,
Tannheimer, SL
|
Mol Cancer Res |
2004 |
20101236 |
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
Geyer, FC,
van Kouwenhove, M,
van de Vijver, MJ,
Horlings, HM,
Reis-Filho, JS,
Ashworth, A,
Lambros, MB,
Natrajan, R,
Sharpe, R,
Turner, N,
Kreike, B,
Mackay, A,
Pearson, A
|
Oncogene |
2010 |
19103595 |
Aberrant receptor internalization and enhanced FRS2-dependent signaling contribute to the transforming activity of the fibroblast growth factor receptor 2 IIIb C3 isoform
Der, CJ,
Harden, TK,
Mitin, N,
Cha, JY,
Maddileti, S
|
J Biol Chem |
2009 |
8205545 |
Preferential alternative splicing in cancer generates a K-sam messenger RNA with higher transforming activity
Sakamoto, H,
Kishi, T,
Koono, M,
Itoh, H,
Ishii, H,
Sasaki, H,
Sugimura, T,
Yoshida, T,
Hattori, Y,
Terada, M
|
Cancer Res |
1994 |
18381441 |
FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival
Kunii, K,
Gorenstein, J,
Hatch, H,
Lutterbach, B,
Yashiro, M,
Davis, L,
Di Bacco, A,
Elbi, C
|
Cancer Res |
2008 |